Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104402790A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104402790A reveals a safer Ezetimibe route. Eliminating silyl protection reduces toxicity and cost for reliable API intermediate supply.